Multimodal imaging for improved diagnosis and treatment of cancers

Cancer

Volumn 121, Issue 6, 2015, Pages 817-827

  Tempany, Clare M C ^a   Jayender, Jagadeesan ^a   Kapur, Tina ^a   Bueno, Raphael ^a   Golby, Alexandra ^a   Agar, Nathalie ^a   Jolesz, Ferenc A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain tumor; Interventional magnetic resonance imaging; Intraoperative monitoring; Lung cancer; Mass spectroscopy; Multimodal imaging; Neuroimaging; Neuronavigation; Prostate biopsy; Prostate cancer

Indexed keywords

BRAIN TUMOR; CANCER DIAGNOSIS; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; GLIOBLASTOMA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMAGE ANALYSIS; IMAGE GUIDED RADIOTHERAPY; LOW LEVEL LASER THERAPY; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MULTIMODAL IMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPERATING ROOM; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; WEDGE RESECTION; DEVICES; DIAGNOSTIC IMAGING; NEOPLASMS; PROCEDURES; RADIOGRAPHY;

DIAGNOSTIC IMAGING; HUMANS; MULTIMODAL IMAGING; NEOPLASMS;

EID: 84924274852     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29012     Document Type: Review

References (55)

1. Jolesz FA. Intraoperative Imaging and Image-Guided Therapy. London, UK: Springer Ltd.; 2013.
2. Brigham and Women's Hospital, Harvard Medical School. The Advanced Multimodality Image-Guided Operating (AMIGO) Suite [video]. Available at: http://www.youtube.com/watch?v5LcZBc-po9yQ. Accessed on August 22, 2014.
3. Tatli S, Gerbaudo VH, Mamede M, Tuncali K, Shyn PB, Silverman SG. Abdominal masses sampled at PET/CT-guided percutaneous biopsy: initial experience with registration of prior PET/CT images. Radiology. 2010;256:305-311.
4. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62:753-764; discussion 764-756.
5. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer. 2005;103:1227-1233.
6. McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110:156-162.
7. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology. 1980;30:907-911.
8. Skirboll SS, Ojemann GA, Berger MS, Lettich E, Winn HR. Functional cortex and subcortical white matter located within gliomas. Neurosurgery. 1996;38:678-684; discussion 684-675.
9. Wu JS, Zhou LF, Tang WJ, et al. Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts. Neurosurgery. 2007;61:935-948; discussion 948-939.
10. Talos IF, Zou KH, Ohno-Machado L, et al. Supratentorial lowgrade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology. 2006;239: 506-513.
11. Nimsky C, Ganslandt O, Hastreiter P, et al. Intraoperative diffusion-tensor MR imaging: shifting of white matter tracts during neurosurgical procedures-initial experience. Radiology. 2005;234: 218-225.
12. Nimsky C, Grummich P, Sorensen AG, Fahlbusch R, Ganslandt O. Visualization of the pyramidal tract in glioma surgery by integrating diffusion tensor imaging in functional neuronavigation. Zentralbl Neurochir. 2005;66:133-141.
13. Black PM, Alexander E 3rd, Martin C, et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery. 1999;45:423-431; discussion 431-423.
14. Upadhyay UM, Golby AJ. Role of pre-and intraoperative imaging and neuronavigation in neurosurgery. Expert Rev Med Devices. 2008; 5:65-73.
15. Gonzalez-Martinez J, Vadera S, Mullin J, et al. Robot-assisted stereotactic laser ablation in medically intractable epilepsy: operative technique. Neurosurgery. 2014;10(suppl 2):167-172; discussion 172-173.
16. Rao MS, Hargreaves EL, Khan AJ,Haffty GB, Danish SF. Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis. Neurosurgery. 2014;74: 658-667; discussion 667.
17. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7:392-401.
18. Agar NY, Golby AJ, Ligon KL, et al. Development of stereotactic mass spectrometry for brain tumor surgery. Neurosurgery. 2011;68: 280-289; discussion 290.
19. American Cancer Society. Cancer Facts & Figures 2014. Atlanta, GA: American Cancer Society; 2014.
20. Moyer VA; US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120-134.
21. Stamatakis L, Siddiqui MM, Nix JW, et al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer. 2013;119: 3359-3366.
22. Klotz L, Emberton M. Management of low risk prostate cancer: active surveillance and focal therapy. Curr Opin Urol. 2014;24:270-279.
23. Abd-Alazeez M, Ahmed HU, Arya M, et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-can it rule out clinically significant prostate cancer [serial online]? Urol Oncol. 2014;32:45 e17-e22.
24. Lange D, Zappavigna C, Hamidizadeh R, Goldenberg SL, Paterson RF, Chew BH. Bacterial sepsis after prostate biopsy-a new perspective. Urology. 2009;74:1200-1205.
25. Zaytoun OM, Vargo EH, Rajan R, Berglund R, Gordon S, Jones JS. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology. 2011;77:1035-1041.
26. Hata N, Hinzaki M, Kacher D, et al. MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology. 2001;220:263-268.
27. Penzkofer T, Tuncali K, Fedorov A, Song S.-E., Tokuda J, Fennessy FM, Vangel M, Kibel AS, Mulkern R, Wells W, Hata N, Tempany CMC. Transperineal in-bore 3T MRI-guided prostate biopsy: a prospective clinical observational study. Radiology. In press.
28. Logan JK, Rais-Bahrami S, Turkbey B, et al. Current status of MRI and ultrasound fusion software platforms for guidance of prostate biopsies [published online ahead of print December 3, 2013]. BJU Int. 2013.
29. Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY. Prostate: MR imaging with an endorectal surface coil. Radiology. 1989; 172:570-574.
30. Tempany CM, Zhou X, Zerhouni EA, et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of 3 MR imaging techniques. Radiology. 1994;192:47-54.
31. Hegde JV, Mulkern RV, Panych LP, et al. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013;37:1035-1054.
32. Barentsz JO, Richenberg J, Clements, et al. European Society of Urogenital Radiology. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22:746-757.
33. Tokuda J, Tunclai K, Iordachita I, et al. In-bore setup and software for 3T MRI-guided transperineal prostate biopsy. Phys Med Biol. 2012;57:5823-5840.
34. Fedorov A, Tuncali K, Fennessy FM, et al. Image registration for targeted MRI-guided transperineal prostate biopsy. J Magn Reson Imaging. 2012;36:987-992.
35. Moradi M, Janoos F, Fedorov A, et al. Two solutions for registration of ultrasound to MRI for image-guided prostate interventions. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:1129-1132.
36. Risholm P, Janoos F, Pursley J, et al. Selection of optimal hyperparameters for estimation of uncertainty in MRI-TRUS registration of the prostate. Med Image Comput Comput Assist Interv. 2012;15(pt 3):107-114.
37. Pursley J, Risholm P, Fedorov A, et al. A Bayesian nonrigid registration method to enhance intraoperative target definition in imageguided prostate procedures through uncertainty characterization. Med Phys. 2012;39:6858-6867.
38. Eggener SE, Scardino PT, Carroll PR, et al. International Task Force on Prostate Cancer and the Focal Lesion Paradigm. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007;178:2260-2267.
39. Bomers JG, Yakar D, Overduin CG, et al. MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. Radiology. 2013;268:451-460.
40. Fennessy F, Fedorov A, Penzkofer T, Tempany CM. Challenges in spatial correlation of multiparametric MRI sequences and pathology findings in prostate cancer staging. Paper presented at: The International Society for Magnetic Resonance in Medicine 21st Scientific Meeting and Exhibition; April 20-26, 2013; Salt Lake City, Utah.
41. Mazaheri Y, Hricak H, Fine SW, et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusionweighted MR: correlation with pathologic tumor volume. Radiology. 2009;252:449-457.
42. Lindner U, Ghai S, Spensieri P, et al. Focal magnetic resonance guided focused ultrasound for prostate cancer: initial North American experience. Can Urol Assoc J. 2012;6:E283-E286.
43. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355: 1763-1771.
44. National Lung Screening Trial Research Team; Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
45. American Cancer Society. Lung Cancer (Non-Small Cell): Detailed Guide. Atlanta, GA: American Cancer Society; 2014. Available at: http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/ non-small-cell-lung-cancer-treating-by-stage. Accessed on August 22, 2014.
46. Swanson SJ. Segmentectomy for lung cancer. Semin Thorac Cardiovasc Surg. 2010;22:244-249.
47. Suzuki K, Nagai K, Yoshida J, et al. Video-assisted thoracoscopic surgery for small indeterminate pulmonary nodules: indications for preoperative marking. Chest. 1999;115:563-568.
48. Wolf AS, Richards WG, Jaklitsch MT, et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg. 2011;92:1819-1825.
49. Shennib H, Bret P. Intraoperative transthoracic ultrasonographic localization of occult lung lesions. Ann Thorac Surg. 1993;55:767-769.
50. Santambrogio R, Montorsi M, Bianchi P, Mantovani A, Ghelma F, Mezzetti M. Intraoperative ultrasound during thoracoscopic procedures for solitary pulmonary nodules. Ann Thorac Surg. 1999;68: 218-222.
51. Nomori H, Horio H, Naruke T, Suemasu K. Fluoroscopy-assisted thoracoscopic resection of lung nodules marked with lipiodol. Ann Thorac Surg. 2002;74:170-173.
52. Moon SW, Wang YP, Jo KH, et al. Fluoroscopy-aided thoracoscopic resection of pulmonary nodule localized with contrast media. Ann Thorac Surg. 1999;68:1815-1820.
53. Gossot D, Miaux Y, Guermazi A, Celerier M, Friga J. The hookwire technique for localization of pulmonary nodules during thoracoscopic resection. Chest. 1994;105:1467-1469.
54. Mayo JR, Clifton JC, Powell TI, et al. Lung nodules: CT-guided placement of microcoils to direct video-assisted thoracoscopic surgical resection. Radiology. 2009;250:576-585.
55. Zheng Y, Gill R, Jayender J, et al. Image-guided video assisted thoracic surgery (iVATS): a phase I/II clinical trial's preliminary report. Paper presented at: Annual Meeting of the American Association for Thoracic Surgery; April 26-30, 2014; Toronto, Ontario, Canada.